Who / What
Twist Bioscience is an American biotechnology company that manufactures synthetic DNA and DNA products. It provides these products to customers across various industries, leveraging its proprietary silicon-based DNA synthesis platform.
Background & History
The company was founded in 2013 in South San Francisco by Emily Leproust, Bill Banyai, and Bill Peck. Since its inception, Twist Bioscience has focused on advancing synthetic biology through high-throughput DNA synthesis. A key milestone includes its representation at a March 2021 tabletop exercise at the Munich Security Conference, simulating a weaponized monkeypox outbreak.
Why Notable
Twist Bioscience is notable for its innovative approach to DNA synthesis, which enables cost-effective and rapid production of genetic material. The company plays a significant role in supporting research and development in pharmaceuticals, agriculture, and chemical production. Its participation in high-profile security exercises highlights its relevance in biosecurity and pandemic preparedness.
In the News
Recently, Twist Bioscience gained attention for its involvement in biosecurity initiatives, such as the 2021 Munich Security Conference exercise. The company continues to expand its product offerings and collaborations, reinforcing its position as a leader in synthetic biology. Its ongoing developments in DNA-based technologies are critical for advancing biotechnology applications worldwide.
